Aspitopic

Aspitopic may be available in the countries listed below.

Ingredient matches for Aspitopic

Etofenamate

Etofenamate is reported as an ingredient of Aspitopic in the following countries:

• Spain

International Drug Name Search

Crevet L

Crevet L may be available in the countries listed below.

Ingredient matches for Crevet L

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Crevet L in the following countries:

• Chile

International Drug Name Search

Thyrostat

Thyrostat may be available in the countries listed below.

Ingredient matches for Thyrostat

Carbimazole

Carbimazole is reported as an ingredient of Thyrostat in the following countries:

• Greece

International Drug Name Search

Hyscopan

Hyscopan may be available in the countries listed below.

Ingredient matches for Hyscopan

Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Hyscopan in the following countries:

• Indonesia

International Drug Name Search

Phyloday

Phyloday may be available in the countries listed below.

Ingredient matches for Phyloday

Theophylline

Theophylline is reported as an ingredient of Phyloday in the following countries:

• India

International Drug Name Search

ratio-Valproic

ratio-Valproic may be available in the countries listed below.

Ingredient matches for ratio-Valproic

Valproic Acid

Valproic Acid is reported as an ingredient of ratio-Valproic in the following countries:

• Canada

International Drug Name Search

Glavitan

Glavitan may be available in the countries listed below.

Ingredient matches for Glavitan

Thiamine

Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Glavitan in the following countries:

• Japan

International Drug Name Search

Cevicort

Cevicort may be available in the countries listed below.

Ingredient matches for Cevicort

Betamethasone

Betamethasone 21-acetate (a derivative of Betamethasone) is reported as an ingredient of Cevicort in the following countries:

• Argentina

Betamethasone 21-acetate and 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Cevicort in the following countries:

• Argentina

International Drug Name Search

Fluvium

Fluvium may be available in the countries listed below.

Ingredient matches for Fluvium

Sodium Fluoride

Sodium Fluoride is reported as an ingredient of Fluvium in the following countries:

• Israel

International Drug Name Search

Itami

Itami may be available in the countries listed below.

Ingredient matches for Itami

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Itami in the following countries:

• Italy

International Drug Name Search

Fluvoxamine

In some countries, this medicine may only be approved for veterinary use.

In the US, Fluvoxamine (fluvoxamine systemic) is a member of the drug class selective serotonin reuptake inhibitors and is used to treat Anxiety and Stress, Body Dysmorphic Disorder, Depression, Eating Disorder, Obsessive Compulsive Disorder, Panic Disorder, Post Traumatic Stress Disorder, Social Anxiety Disorder and Trichotillomania.

US matches:

• Fluvoxamine


• Fluvoxamine Extended-Release Capsules


• Fluvoxamine Maleate

UK matches:

• Fluvoxamine 50mg & 100mg Film-Coated Tablets (Wockhardt UK Ltd) (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06AB08

CAS registry number (Chemical Abstracts Service)

0054739-18-3

Chemical Formula

C15-H21-F3-N2-O2

Molecular Weight

318

Therapeutic Category

Antidepressant: Selective serotonin reuptake inhibitor (SSRI)

Chemical Name

1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-, O-(2-aminoethyl)oxime, (E)-

Foreign Names

• Fluvoxaminum (Latin)
• Fluvoxamin (German)
• Fluvoxamine (French)
• Fluvoxamina (Spanish)

Generic Names

• Fluvoxamine (OS: BAN, DCF)
• Fluvoxamine Maleate (OS: USAN, BANM)
• DU 23000 (IS: Duphar)
• MK 264 (IS)
• Fluvoxamine Maleate (PH: BP 2010, USP 32, Ph. Eur. 6)
• Fluvoxamini maleas (PH: Ph. Eur. 6)

Brand Names

• Floxyfral
  Solvay, Tunisia



• Vuminix
  Sun Pharma, Mexico



• Anwu
  Taiwan Biotech, Taiwan



• Apo-Fluvoxamine
  Apotex, Canada



• Avoxin
  Krka, Slovenia



• CO Fluvoxamine
  Cobalt, Canada



• Depromel
  Meiji Seika Kaisha, Japan



• Dumirox
  Solvay, Spain; Solvay, Italy



• Dumyrox
  Solvay, Greece; Solvay, Portugal



• Faverin
  Sigma, Australia; Solvay, Bahrain; Solvay, United Kingdom; Solvay, Hong Kong; Solvay, Ireland; Solvay, Malta; Solvay, Oman; Solvay, Philippines; Solvay, Singapore; Solvay, Turkey; Solvay, South Africa



• Faverin (veterinary use)
  Solvay, United Kingdom



• Favoxil
  Agis, Israel



• Fevarin
  Solvay, Bulgaria; Solvay, Czech Republic; Solvay, Germany; Solvay, Denmark; Solvay, Estonia; Solvay, Finland; Solvay, Georgia; Solvay, Croatia (Hrvatska); Solvay, Hungary; Solvay, Italy; Solvay, Lithuania; Solvay, Latvia; Solvay, Netherlands; Solvay, Norway; Solvay, Poland; Solvay, Romania; Solvay, Russian Federation; Solvay, Sweden; Solvay, Slovakia



• Flox-ex
  Sandoz, Switzerland



• Floxyfral
  Solvay, Austria; Solvay, Belgium; Solvay, France; Solvay, Luxembourg; Solvay Pharma, Switzerland



• Floxyfral junior (pediatric)
  Solvay Pharma, Switzerland



• FluvoHexal
  Hexal, Germany



• Fluvosol
  Stada, Finland



• Fluvoxadura
  Mylan dura, Germany



• Fluvoxamin AL
  Aliud, Germany; Aliud Pharma, Bulgaria



• Fluvoxamin Stada
  Stada, Germany



• Fluvoxamin Synthon
  Synthon, Germany



• Fluvoxamina EG
  EG, Italy



• Fluvoxamina Sandoz
  Sandoz, Spain; Sandoz, Portugal



• Fluvoxamina Teva
  Teva, Spain



• Fluvoxamine Actavis
  Actavis, France



• Fluvoxamine EG
  EG Labo, France; Eurogenerics, Belgium



• Fluvoxamine maleaat EB
  Eurobase, Netherlands



• Fluvoxamine maleate Synthon
  Synthon, Singapore



• Fluvoxamine Maleate
  Actavis, United States; Apotex, United States; Caraco, United States; Eon, United States; Genpharm, United States; Mylan, United States; Sandoz, United States; Synthon, United States; Teva USA, United States; Torpharm, United States



• Fluvoxamine Mylan
  Mylan, France



• Fluvoxamine Sandoz
  Sandoz, Belgium; Sandoz, France; Sandoz, Luxembourg



• Fluvoxamine Teva
  Elvim, Latvia; Teva, Belgium; Teva Santé, France



• Fluvoxamine
  CP, Malta; Wockhardt, United Kingdom



• Fluvoxamine-EG
  Eurogenerics, Luxembourg



• Fluvoxamine-Hexal
  Hexal, South Africa



• Fluvoxamine-maleaat A
  Apothecon, Netherlands



• Fluvoxaminemaleaat Actavis
  Actavis, Netherlands



• Fluvoxaminemaleaat CF
  Centrafarm, Netherlands



• Fluvoxaminemaleaat Katwijk
  Apotex Europe, Netherlands



• Fluvoxaminemaleaat Merck
  Mylan, Netherlands



• Fluvoxaminemaleaat PCH
  Pharmachemie, Netherlands



• Fluvoxaminemaleaat ratiopharm
  ratiopharm, Netherlands



• Fluvoxaminemaleaat Sandoz
  Sandoz, Netherlands



• Fluvoxaminemaleaat Solvay Pharma
  Solvay, Netherlands



• Fluvoxaminemaleaat Stada
  Stada, Netherlands



• Fluvoxaminemaleaat
  Genthon, Netherlands; Synthon, Netherlands



• Fluvoxamin-neuraxpharm
  Neuraxpharm, Germany



• Fluvoxamin-ratiopharm
  Ratiopharm, Germany



• Fluvoxamin-Teva
  Teva, Germany



• Fluvoxin
  Sun, India



• Luvox
  Italmex, Mexico; Jazz, United States; Solvay, Australia; Solvay, Canada; Solvay, China; Solvay, Indonesia; Solvay, Malaysia; Solvay, Peru; Solvay, Taiwan; Solvay, South Africa; Solvay Seiyaku K.K, Japan; Synthesis, Colombia



• Maveral
  Bayer, Italy



• Movox
  Alphapharm, Australia



• Myroxine
  Novartis, Greece



• PMS-Fluvoxamine
  Pharmascience, Canada



• ratio-Fluvoxamine
  ratiopharm, Canada



• Relafin
  General Pharma, Bangladesh



• Ruibile
  Tsinghua Yuanxing, China



• Sandoz Fluvoxamine
  Sandoz, Canada



• Sorest
  Ranbaxy, India



• Uvox
  Solvay, India



• Voxam
  Sandoz, Australia



• Voxamin
  Incobra, Colombia

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Etindrax

Etindrax may be available in the countries listed below.

Ingredient matches for Etindrax

Allopurinol

Allopurinol is reported as an ingredient of Etindrax in the following countries:

• Mexico

International Drug Name Search

Amineurin

Amineurin may be available in the countries listed below.

Ingredient matches for Amineurin

Amitriptyline

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Amineurin in the following countries:

• Germany


• Luxembourg

International Drug Name Search

Siyafen

Siyafen may be available in the countries listed below.

Ingredient matches for Siyafen

Ibuprofen

Ibuprofen is reported as an ingredient of Siyafen in the following countries:

• Turkey

International Drug Name Search

DocMorris NAC Hustenlöser

DocMorris NAC Hustenlöser may be available in the countries listed below.

Ingredient matches for DocMorris NAC Hustenlöser

Acetylcysteine

Acetylcysteine is reported as an ingredient of DocMorris NAC Hustenlöser in the following countries:

• Germany

International Drug Name Search

Noval

Noval may be available in the countries listed below.

Ingredient matches for Noval

Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Noval in the following countries:

• Greece

International Drug Name Search

Depin

Depin may be available in the countries listed below.

Ingredient matches for Depin

Nifedipine

Nifedipine is reported as an ingredient of Depin in the following countries:

• Bahrain


• India


• Myanmar

International Drug Name Search

Somerol

Somerol may be available in the countries listed below.

Ingredient matches for Somerol

Methylprednisolone

Methylprednisolone is reported as an ingredient of Somerol in the following countries:

• Indonesia

International Drug Name Search

Afazol Grin

Afazol Grin may be available in the countries listed below.

Ingredient matches for Afazol Grin

Naphazoline

Naphazoline hydrochloride (a derivative of Naphazoline) is reported as an ingredient of Afazol Grin in the following countries:

• Mexico

International Drug Name Search

Bisolvon

Bisolvon may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Bisolvon

Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Bisolvon in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Bosnia & Herzegowina


• Brazil


• Chile


• Colombia


• Croatia (Hrvatska)


• Egypt


• Finland


• France


• Germany


• Greece


• Guyana


• Hong Kong


• Iceland


• Indonesia


• Iraq


• Ireland


• Italy


• Japan


• Jordan


• Kenya


• Kuwait


• Libya


• Luxembourg


• Malta


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Poland


• Portugal


• Qatar


• Romania


• Saudi Arabia


• Serbia


• Singapore


• Slovenia


• South Africa


• Spain


• Sri Lanka


• Sudan


• Sweden


• Switzerland


• Thailand


• United Arab Emirates


• United Kingdom


• Venezuela


• Vietnam

Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Bisolvon in the following countries:

• Australia

International Drug Name Search

Relax

Relax may be available in the countries listed below.

Ingredient matches for Relax

Buspirone

Buspirone hydrochloride (a derivative of Buspirone) is reported as an ingredient of Relax in the following countries:

• Dominican Republic

International Drug Name Search

Cerumex

Cerumex may be available in the countries listed below.

Ingredient matches for Cerumex

Docusate

Docusate Sodium is reported as an ingredient of Cerumex in the following countries:

• Argentina

International Drug Name Search

Tradelia seven

Tradelia seven may be available in the countries listed below.

Ingredient matches for Tradelia seven

Estradiol

Estradiol is reported as an ingredient of Tradelia seven in the following countries:

• Germany

International Drug Name Search

Novemina

Novemina may be available in the countries listed below.

Ingredient matches for Novemina

Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Novemina in the following countries:

• Argentina

International Drug Name Search

Alendronato Calox

Alendronato Calox may be available in the countries listed below.

Ingredient matches for Alendronato Calox

Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronato Calox in the following countries:

• Venezuela

International Drug Name Search

Magnesium Gluconate

In the US, Magnesium Gluconate (magnesium gluconate systemic) is a member of the drug class minerals and electrolytes and is used to treat Dietary Supplementation and Hypomagnesemia.

US matches:

• Magnesium Gluconate


• Magnesium Gluconate Liquid

Scheme

Ph. Eur.

ATC (Anatomical Therapeutic Chemical Classification)

A12CC03

CAS registry number (Chemical Abstracts Service)

0003632-91-5

Chemical Formula

C12-H22-Mg-O14

Molecular Weight

414

Therapeutic Category

Mineral supplement

Chemical Name

Magnesium D-gluconate

Foreign Name

• D-Gluconsäure, Magnesiumsalz (German)

Generic Names

• Magnesii gluconas (PH: Ph. Eur. 6)
• Magnesium Gluconate (PH: USP 32, Ph. Eur. 6, BP 2010)

Brand Names

• Magnesio Gluconate
  Arion, Peru



• Magnesium Chelate
  Alegia, Peru



• Magnesium gluconicum LH
  Lannacher, Austria



• Magnesium Glycocolle Lafarge
  SERP, Tunisia



• Magnésium Oligosol
  Labcatal, France



• Ultra Mg
  Melisana, Belgium



• Ultra-Mg
  Melisana, Luxembourg



• Magnerot
  Wörwag Pharma, Germany



• Oligostim Magnésium
  Boiron, France

International Drug Name Search

Glossary

PH	Pharmacopoeia Name
Ph. Eur.	European Pharmacopoeia

Click for further information on drug naming conventions and International Nonproprietary Names.

Clofibrate

In the US, Clofibrate (clofibrate systemic) is a member of the drug class fibric acid derivatives and is used to treat High Cholesterol, Hyperlipoproteinemia, Hyperlipoproteinemia Type III - Elevated beta-VLDL IDL, Hyperlipoproteinemia Type IV - Elevated VLDL and Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL.

US matches:

• Clofibrate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AB01

CAS registry number (Chemical Abstracts Service)

0000637-07-0

Chemical Formula

C12-H15-Cl-O3

Molecular Weight

242

Therapeutic Category

Antilipemic agent, fibrate

Chemical Name

Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-, ethyl ester

Foreign Names

• Clofibratum (Latin)
• Clofibrat (German)
• Clofibrate (French)
• Clofibrato (Spanish)

Generic Names

• Clofibrate (OS: USAN, DCF, JAN, BAN)
• Clofibrato (OS: DCIT)
• AY 61123 (IS)
• Chlorfenisate (IS)
• Chlorophenisate (IS)
• ICI 28257 (IS)
• Lipomid (IS)
• NSC 79389 (IS)
• Sklerolip (IS)
• Clofibrat (PH: Ph. Eur. 6)
• Clofibrate (PH: BP 2010, JP XV, USP 32, Ph. Eur. 6)
• Clofibratum (PH: Ph. Eur. 6)

Brand Names

• Binograc
  Kotobuki Seiyaku, Japan



• Clobrate
  Johnson, Taiwan



• Clofibrate
  Banner Pharmacaps, United States; Gallipot, United States; USL Pharma, United States



• Elpi
  Elea, Argentina



• Hypocerol
  Fuso Pharmaceutical, Japan



• Lipilim
  Atlantic, Hong Kong

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tohmol

Tohmol may be available in the countries listed below.

Ingredient matches for Tohmol

Dipyridamole

Dipyridamole is reported as an ingredient of Tohmol in the following countries:

• Japan

International Drug Name Search

Twin Spot

Twin Spot may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Twin Spot

Pyriproxyfen

Pyriproxyfen is reported as an ingredient of Twin Spot in the following countries:

• Netherlands

International Drug Name Search

Cefixima Germed

Cefixima Germed may be available in the countries listed below.

Ingredient matches for Cefixima Germed

Cefixime

Cefixime is reported as an ingredient of Cefixima Germed in the following countries:

• Portugal

International Drug Name Search

Apo-Benzydamine

Apo-Benzydamine may be available in the countries listed below.

Ingredient matches for Apo-Benzydamine

Benzydamine

Benzydamine is reported as an ingredient of Apo-Benzydamine in the following countries:

• Canada

International Drug Name Search

Fluimukan

Fluimukan may be available in the countries listed below.

Ingredient matches for Fluimukan

Acetylcysteine

Acetylcysteine is reported as an ingredient of Fluimukan in the following countries:

• Bosnia & Herzegowina


• Croatia (Hrvatska)


• Slovenia

International Drug Name Search

Carnidazole

In some countries, this medicine may only be approved for veterinary use.

Scheme

Prop.INN

CAS registry number (Chemical Abstracts Service)

0042116-76-7

Chemical Formula

C8-H12-N4-O3-S

Molecular Weight

244

Therapeutic Category

Antiprotozoal

Chemical Name

Carbamothioic acid, [2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-, O-methyl ester

Foreign Names

• Carnidazolum (Latin)
• Carnidazol (German)
• Carnidazole (French)
• Carnidazol (Spanish)

Generic Names

• Carnidazole (OS: BAN, USAN)
• R 25831 (IS: Janssen)

Brand Names

• Spartrix (veterinary use)
  Janssen Animal Health, Belgium; Janssen Animal Health, Germany; Janssen Animal Health, Netherlands; Laboratoires Moureau, France; Petlife, United Kingdom; Roenfri, Germany; Wildlife, United States

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Gencef

Gencef may be available in the countries listed below.

Ingredient matches for Gencef

Cefepime

Cefepime Hydrochloride (a derivative of Cefepime) is reported as an ingredient of Gencef in the following countries:

• Greece

International Drug Name Search

Balkaprofen

Balkaprofen may be available in the countries listed below.

Ingredient matches for Balkaprofen

Ibuprofen

Ibuprofen is reported as an ingredient of Balkaprofen in the following countries:

• Bahrain


• Oman


• Tunisia

International Drug Name Search

Neochinosol

Neochinosol may be available in the countries listed below.

Ingredient matches for Neochinosol

Ethacridine

Ethacridine lactate (a derivative of Ethacridine) is reported as an ingredient of Neochinosol in the following countries:

• Germany

International Drug Name Search

Droplix

Droplix may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Droplix

Dimpylate

Dimpylate is reported as an ingredient of Droplix in the following countries:

• Portugal

International Drug Name Search

Picola

Picola may be available in the countries listed below.

Ingredient matches for Picola

Econazole

Econazole nitrate (a derivative of Econazole) is reported as an ingredient of Picola in the following countries:

• Peru

International Drug Name Search

Tatumcef

Tatumcef may be available in the countries listed below.

Ingredient matches for Tatumcef

Ceftazidime

Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Tatumcef in the following countries:

• Taiwan

International Drug Name Search

Lipreren

Lipreren may be available in the countries listed below.

Ingredient matches for Lipreren

Lisinopril

Lisinopril is reported as an ingredient of Lipreren in the following countries:

• Chile

International Drug Name Search

Grifulvin

Grifulvin may be available in the countries listed below.

Ingredient matches for Grifulvin

Griseofulvin

Griseofulvin is reported as an ingredient of Grifulvin in the following countries:

• Bangladesh

International Drug Name Search

Tab Peptid

Tab Peptid may be available in the countries listed below.

Ingredient matches for Tab Peptid

Famotidine

Famotidine is reported as an ingredient of Tab Peptid in the following countries:

• Bangladesh

International Drug Name Search

Dimétane

Dimétane may be available in the countries listed below.

Ingredient matches for Dimétane

Pholcodine

Pholcodine is reported as an ingredient of Dimétane in the following countries:

• France

International Drug Name Search

dexrazoxane

Generic Name: dexrazoxane (dex ray ZOX ane)

Brand Names: Totect, Zinecard

What is dexrazoxane?

Dexrazoxane is used to protect the heart and other tissues from harmful side effects caused by certain cancer medications.

The Zinecard brand of dexrazoxane is used in women who are receiving doxorubicin for metastatic breast cancer.

The Totect brand of dexrazoxane is used in men or women to treat a condition called extravasation (es-TRA-va-ZAY-shun). Extravasation happens when an injected medicine escapes from the blood vessels and circulates into tissues in the body. Serious tissue damage can occur when extravasation happens during injection of certain cancer medications.

Dexrazoxane may also be used for purposes not listed in this medication guide.

What is the most important information I should know about dexrazoxane?

You should not receive Totect if you are pregnant. It could harm the unborn baby. If possible before you receive Totect, tell your doctor if you are pregnant. It is not known whether Zinecard will harm an unborn baby. You should not receive this medication if your chemotherapy does not include doxorubicin or a similar medication such as daunorubicin (Cerubidine), epirubicin (Ellence), idarubicin (Idamycin), or mitoxantrone (Novantrone).

Before you receive dexrazoxane, tell your doctor if you have liver or kidney disease, or if you are pregnant or breast-feeding.

Tell your doctor at once if you have serious side effects such as fever, chills, body aches, flu symptoms, easy bruising or bleeding, or sores your mouth or throat.

In an emergency situation it may not be possible before you are treated to tell your caregivers about your health conditions or if you are pregnant or breast feeding. Make sure any doctor caring for you afterward knows that you have received Totect.

What should I discuss with my health care provider before receiving dexrazoxane?

You should not receive Zinecard if your chemotherapy does not include doxorubicin or a similar medication such as:

• 
  

  daunorubicin (Cerubidine);

  
  


• 
  

  epirubicin (Ellence);

  
  


• 
  

  idarubicin (Idamycin); or

  
  


• 
  

  mitoxantrone (Novantrone);

  
  

If possible before you receive dexrazoxane, tell your doctor if you have:

• 
  

  liver disease;

  
  


• 
  

  kidney disease; or

  
  


• 
  

  if you are pregnant or breast-feeding.

  
  

Zinecard is rated as FDA pregnancy category C. It is not known whether Zinecard will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Totect is rated as FDA pregnancy category D. Do not use Totect if you are pregnant. It could harm the unborn baby. If possible before you receive Zinecard, tell your doctor if you are pregnant. It is not known whether dexrazoxane passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using dexrazoxane. In an emergency situation, it may not be possible before you are treated with Totect to tell your caregivers if you are pregnant or breast feeding. Make sure any doctor caring for your pregnancy or your baby knows you have received this medication.

How is dexrazoxane given?

Dexrazoxane is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting.

Totect is usually started within 6 hours after extravasation, and continued once daily for 3 days.

Zinecard is usually started 30 minutes before you receive your doxorubicin injection.

Dexrazoxane can add to the bone marrow lowering effects of chemotherapy. This can weaken your immune system, making it easier for you to get sick from being around others who are ill.

To be sure this medication is not causing harmful effects, your blood cells and kidney function will need to be tested often. Do not miss any follow up visits to your doctor for blood or urine tests.

What happens if I miss a dose?

Since dexrazoxane is given by a healthcare professional as part of your chemotherapy treatment, you are not likely to miss a dose.

Call your doctor if you miss a chemotherapy appointment.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid after receiving dexrazoxane?

Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.

Dexrazoxane side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Tell your doctor at once if you have any of these serious side effects:

• 
  

  fever, chills, body aches, flu symptoms, sores in your mouth and throat;

  
  


• 
  

  easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin; or

  
  


• 
  

  bruising, swelling, warmth, redness, oozing, or bleeding of any surgical incision.

  
  

Less serious side effects may include:

• 
  

  swelling in your hands or feet;

  
  


• 
  

  hair loss;

  
  


• 
  

  nausea, vomiting, diarrhea, loss of appetite;

  
  


• 
  

  sore throat, trouble swallowing;

  
  


• 
  

  dizziness, tired feeling; or

  
  


• 
  

  pain, swelling, or redness where the medicine was injected.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Dexrazoxane Dosing Information

Usual Adult Dose for Cardiomyopathy Prophylaxis:

Dexrazoxane (marketed as Zinecard)
For use in reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m2 and who will continue to receive doxorubicin therapy to maintain tumor control:

The recommended dosage ratio of dexrazoxane:doxorubicin is 10:1 (for example: 500 mg/m2 dexrazoxane:50 mg/m2 doxorubicin).

After completing the infusion of dexrazoxane, and prior to a total elapsed time of 30 minutes (from the beginning of the dexrazoxane infusion), the intravenous injection of doxorubicin should be given.

Usual Adult Dose for Extravasation:

Dexrazoxane (marketed as Totect)
For use in the treatment of extravasation resulting from IV anthracycline chemotherapy:

Dexrazoxane should be given once daily for three consecutive days. The first infusion should be initiated as soon as possible and within the first six hours after extravasation.

The recommended doses are:
Day one: 1000 mg/m2
Day two: 1000 mg/m2
Day three: 500 mg/m2

The maximum recommended doses are:
Day one: 2000 mg
Day two: 2000 mg
Day three: 1000 mg

The dose should be administered as an intravenous infusion over 1 to 2 hours in a large caliber vein in an extremity/area other than the one affected by the extravasation.

Cooling procedures such as ice packs, if used, should be removed from the area at least 15 minutes before dexrazoxane administration in order to allow sufficient blood flow to the area of extravasation. Treatment on day 2 and day 3 should start at the same hour (plus or minus 3 hours) as on the first day.

Usual Pediatric Dose for Cardiomyopathy Prophylaxis:

Dexrazoxane dose is based on a 10:1 ratio of the doxorubicin dose (example: 300 mg/m2 dexrazoxane; 30 mg/m2 doxorubicin)

Dexrazoxane should be administered 30 minutes before doxorubicin.

This regimen has been used in patients with high-risk acute lymphoblastic leukemia.

What other drugs will affect dexrazoxane?

Some cancer medications may be less effective if they are used with dexrazoxane. Tell your doctor if your chemotherapy medications include:

• 
  

  fluorouracil (5-FU, Adrucil);

  
  


• 
  

  cyclophosphamide (Cytoxan, Neosar).

  
  

This list is not complete and other drugs may interact with dexrazoxane. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More dexrazoxane resources

• Dexrazoxane Side Effects (in more detail)
• Dexrazoxane Dosage
• Dexrazoxane Use in Pregnancy & Breastfeeding
• Dexrazoxane Support Group
• 0 Reviews for Dexrazoxane - Add your own review/rating

• dexrazoxane Intravenous Advanced Consumer (Micromedex) - Includes Dosage Information


• Dexrazoxane Prescribing Information (FDA)


• Dexrazoxane MedFacts Consumer Leaflet (Wolters Kluwer)


• Dexrazoxane Professional Patient Advice (Wolters Kluwer)


• Dexrazoxane Hydrochloride Monograph (AHFS DI)


• Totect Consumer Overview


• Totect Prescribing Information (FDA)


• Zinecard Prescribing Information (FDA)

Compare dexrazoxane with other medications

• Cardiomyopathy Prophylaxis
• Extravasation

Where can I get more information?

• Your doctor or pharmacist can provide more information about dexrazoxane.

See also: dexrazoxane side effects (in more detail)

Caduet

In the US, Caduet (amlodipine/atorvastatin systemic) is a member of the following drug classes: antihyperlipidemic combinations, antihypertensive combinations and is used to treat Angina and High Blood Pressure.

US matches:

• Caduet

Ingredient matches for Caduet

Amlodipine

Amlodipine is reported as an ingredient of Caduet in the following countries:

• Bulgaria


• Indonesia


• Poland


• Slovenia

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Caduet in the following countries:

• Australia


• Austria


• Bahrain


• Canada


• China


• Croatia (Hrvatska)


• France


• Hungary


• Malta


• Oman


• Singapore


• Slovakia


• South Africa


• Switzerland


• United States

Atorvastatin

Atorvastatin is reported as an ingredient of Caduet in the following countries:

• Bulgaria


• Poland


• Slovenia

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Caduet in the following countries:

• Australia


• Austria


• Bahrain


• Canada


• China


• Croatia (Hrvatska)


• France


• Hungary


• Indonesia


• Malta


• Oman


• Singapore


• Slovakia


• South Africa


• Switzerland


• United States

International Drug Name Search

Tafen

Tafen may be available in the countries listed below.

Ingredient matches for Tafen

Budesonide

Budesonide is reported as an ingredient of Tafen in the following countries:

• Bosnia & Herzegowina


• Croatia (Hrvatska)


• Romania


• Slovakia

International Drug Name Search

bleomycin Injection

blee-oh-MYE-sin

Injection route(Powder for Solution)

Pulmonary fibrosis is the most severe toxicity and its most frequent presentation is pneumonitis occasionally progressing to pulmonary fibrosis. Its occurrence is higher in elderly patients and in those receiving greater than 400 units total dose, but pulmonary toxicity has been observed in young patients and those treated with low doses. A severe idiosyncratic reaction consisting of hypotension, mental confusion, fever, chills, and wheezing has been reported in lymphoma patients treated with bleomycin for injection .

Commonly used brand name(s)

In the U.S.

• Blenoxane

Available Dosage Forms:

• Powder for Solution

Therapeutic Class: Antibiotic

Uses For bleomycin

Bleomycin belongs to the general group of medicines called antineoplastics. It is used to treat several types of cancer, including cervix and uterus cancer, head and neck cancer, testicle and penile cancer, and certain types of lymphoma. Bleomycin also may used for other conditions, as determined by your doctor.

Bleomycin seems to act by interfering with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by bleomycin, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like darkening of skin or hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.

Before you begin treatment with bleomycin, you and your doctor should talk about the good bleomycin will do as well as the risks of using it.

Bleomycin is to be administered only by or under the immediate supervision of your doctor.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, bleomycin is used in certain patients with the following medical conditions:

• Bone cancer


• Kaposi's sarcoma


• Malignant melanoma


• Mycosis fungoides (a type of lymphoma)


• Skin cancer


• Thyroid cancer


• Verruca vulgaris (warts)

For patients being treated with bleomycin for warts:

• Bleomycin is used to treat severe cases of warts when other treatments have not worked.


• Before using bleomycin, tell your doctor if you have problems with circulation. Bleomycin can cause paleness or coldness in fingers treated for warts.


• Bleomycin is injected directly into the wart. Because it is not absorbed into the body, it does not cause loss of hair, lung problems, or other unwanted effects described above. However, it may cause burning or pain at the place of injection. Skin rash or itching, nail loss, and pain or coldness in the finger where bleomycin was injected have also been reported.

Before Using bleomycin

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For bleomycin, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to bleomycin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Although there is no specific information comparing use of bleomycin in children with use in other age groups, bleomycin is not expected to cause different side effects or problems in children than it does in adults.

Geriatric

Lung problems are more likely to occur in elderly patients (over 70 years of age), who are usually more sensitive to the effects of bleomycin.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	D	Studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking bleomycin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using bleomycin with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Brentuximab Vedotin


• Rotavirus Vaccine, Live

Using bleomycin with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Adenovirus Vaccine Type 4, Live


• Adenovirus Vaccine Type 7, Live


• Bacillus of Calmette and Guerin Vaccine, Live


• Influenza Virus Vaccine, Live


• Measles Virus Vaccine, Live


• Mumps Virus Vaccine, Live


• Rotavirus Vaccine, Live


• Rubella Virus Vaccine, Live


• Smallpox Vaccine


• Typhoid Vaccine


• Varicella Virus Vaccine


• Yellow Fever Vaccine

Using bleomycin with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Phenytoin

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of bleomycin. Make sure you tell your doctor if you have any other medical problems, especially:

• Kidney disease—Effects of bleomycin may be increased because of slower removal from the body

• Liver disease—Bleomycin can cause liver problems

• Lung disease—Bleomycin may worsen the condition

Proper Use of bleomycin

Bleomycin is sometimes given together with certain other medicines. If you are using a combination of medicines, it is important that you receive each medicine at the proper time. If you are taking some of these medicines by mouth, ask your health care professional to help you plan a way to take them at the right times.

Bleomycin often causes nausea, vomiting, and loss of appetite. However, it is very important that you continue to receive the medicine, even if you begin to feel ill. Ask your health care professional for ways to lessen these effects.

Dosing

The dose of bleomycin will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of bleomycin. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

Precautions While Using bleomycin

It is very important that your doctor check your progress at regular visits to make sure that bleomycin is working properly and to check for unwanted effects.

Before having any kind of surgery (including dental surgery) or emergency treatment, tell the medical doctor or dentist in charge that you are receiving or have received bleomycin.

Tell your doctor if you smoke. The risk of lung problems is increased in people who smoke.

bleomycin Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

More common

• Fever and chills (occurring within 3 to 6 hours after a dose)

Less common

• Confusion


• faintness


• wheezing

Rare

• Chest pain (sudden severe)


• weakness in arms or legs (sudden)

Check with your doctor as soon as possible if any of the following side effects occur:

More common

• Cough


• shortness of breath


• sores in mouth and on lips

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Darkening or thickening of skin


• dark stripes on skin


• itching of skin


• skin rash or colored bumps on fingertips, elbows, or palms


• skin redness or tenderness


• swelling of fingers


• vomiting and loss of appetite

Less common

• Changes in fingernails or toenails


• weight loss

Bleomycin may cause a temporary loss of hair in some people. After treatment has ended, normal hair growth should return, although it may take several months.

Side effects that affect your lungs (for example, cough and shortness of breath) may be more likely to occur if you smoke.

After you stop using bleomycin, it may still produce some side effects that need attention. During this period of time, check with your doctor immediately if you notice the following side effects:

• Cough


• shortness of breath

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: bleomycin Injection side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More bleomycin Injection resources

• Bleomycin Injection Side Effects (in more detail)
• Bleomycin Injection Use in Pregnancy & Breastfeeding
• Bleomycin Injection Drug Interactions
• Bleomycin Injection Support Group
• 0 Reviews for Bleomycin Injection - Add your own review/rating

Compare bleomycin Injection with other medications

• Hodgkin's Lymphoma
• Malignant Pleural Effusion
• Non-Hodgkin's Lymphoma
• Squamous Cell Carcinoma
• Testicular Cancer

Nexiam IV

Nexiam IV may be available in the countries listed below.

Ingredient matches for Nexiam IV

Esomeprazole

Esomeprazole sodium (a derivative of Esomeprazole) is reported as an ingredient of Nexiam IV in the following countries:

• South Africa

International Drug Name Search

Carafate

Carafate is a brand name of sucralfate, approved by the FDA in the following formulation(s):

CARAFATE (sucralfate - suspension; oral)

• 
  Manufacturer: APTALIS PHARMA US
  
  Approval date: December 16, 1993
  
  Strength(s): 1GM/10ML ^[RLD]

CARAFATE (sucralfate - tablet; oral)

• 
  Manufacturer: APTALIS PHARMA US
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 1GM ^[RLD][AB]

Has a generic version of Carafate been approved?

Yes. The following products are equivalent to Carafate:

sucralfate tablet; oral

• 
  Manufacturer: NOSTRUM LABS
  
  Approval date: June 8, 1998
  
  Strength(s): 1GM ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: March 29, 1996
  
  Strength(s): 1GM ^[AB]

Note: No generic formulation of the following product is available.

• sucralfate - suspension; oral

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Carafate. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Carafate.

See also...

• Carafate Consumer Information (Drugs.com)
• Carafate Consumer Information (Wolters Kluwer)
• Carafate Suspension Consumer Information (Wolters Kluwer)
• Carafate Consumer Information (Cerner Multum)
• Carafate Advanced Consumer Information (Micromedex)
• Carafate AHFS DI Monographs (ASHP)
• Sucralfate Consumer Information (Wolters Kluwer)
• Sucralfate Suspension Consumer Information (Wolters Kluwer)
• Sucralfate Consumer Information (Cerner Multum)
• Sulcrate Suspension Plus Advanced Consumer Information (Micromedex)
• Sucralfate Advanced Consumer Information (Micromedex)
• Sucralfate AHFS DI Monographs (ASHP)

Nitten DM Solone

Nitten DM Solone may be available in the countries listed below.

Ingredient matches for Nitten DM Solone

Dexamethasone

Dexamethasone 21-(sodium 3-sulfobenzoate) (a derivative of Dexamethasone) is reported as an ingredient of Nitten DM Solone in the following countries:

• Japan

International Drug Name Search

Suscard

Suscard may be available in the countries listed below.

UK matches:

• Suscard Buccal Tablets
• Suscard Buccal Tablets (SPC)

Ingredient matches for Suscard

Nitroglycerin

Nitroglycerin is reported as an ingredient of Suscard in the following countries:

• Sweden


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Pethidine Renaudin

Pethidine Renaudin may be available in the countries listed below.

Ingredient matches for Pethidine Renaudin

Pethidine

Pethidine is reported as an ingredient of Pethidine Renaudin in the following countries:

• Tunisia

International Drug Name Search

Tamoxifene Segix

Tamoxifene Segix may be available in the countries listed below.

Ingredient matches for Tamoxifene Segix

Tamoxifen

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxifene Segix in the following countries:

• Italy

International Drug Name Search

Debeone

Debeone may be available in the countries listed below.

Ingredient matches for Debeone

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Debeone in the following countries:

• Mexico

International Drug Name Search

Pilokarp

Pilokarp may be available in the countries listed below.

Ingredient matches for Pilokarp

Pilocarpine

Pilocarpine hydrochloride (a derivative of Pilocarpine) is reported as an ingredient of Pilokarp in the following countries:

• Slovakia

International Drug Name Search

Septrin

Septrin may be available in the countries listed below.

UK matches:

• Septrin Adult Suspension (Aspen Europe GmbH) (SPC)
• Septrin for Infusion (SPC)
• Septrin Forte Tablets (SPC)
• Septrin Paediatric Suspension (SPC)
• Septrin Tablets (SPC)

Ingredient matches for Septrin

Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Septrin in the following countries:

• Australia


• Bahrain


• Bangladesh


• Chile


• Colombia


• Ethiopia


• Georgia


• Greece


• Hong Kong


• Indonesia


• Iran


• Ireland


• Israel


• Kuwait


• Malta


• Mexico


• Oman


• Peru


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Spain


• Taiwan


• Turkey


• United Arab Emirates


• United Kingdom

Trimethoprim

Trimethoprim is reported as an ingredient of Septrin in the following countries:

• Australia


• Bahrain


• Bangladesh


• Chile


• Colombia


• Ethiopia


• Georgia


• Greece


• Hong Kong


• Indonesia


• Iran


• Ireland


• Israel


• Kuwait


• Malta


• Mexico


• Oman


• Peru


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Spain


• Taiwan


• Turkey


• United Arab Emirates


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Loxomarin

Loxomarin may be available in the countries listed below.

Ingredient matches for Loxomarin

Loxoprofen

Loxoprofen sodium salt (a derivative of Loxoprofen) is reported as an ingredient of Loxomarin in the following countries:

• Japan

International Drug Name Search

Flumexil

Flumexil may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Flumexil

Flumequine

Flumequine is reported as an ingredient of Flumexil in the following countries:

• Italy


• Portugal

International Drug Name Search

Lumbolin

Lumbolin may be available in the countries listed below.

Ingredient matches for Lumbolin

Heparin

Heparin is reported as an ingredient of Lumbolin in the following countries:

• Poland

International Drug Name Search

Dandrex Lotion

Pronunciation: se-LEE-nee-um
Generic Name: Selenium
Brand Name: Examples include Dandrex and Selsun Blue

Dandrex Lotion is used for:

Treating dandruff and other conditions of the scalp and skin.

Dandrex Lotion is a cytostatic agent. It works by reducing skin cell growth and inhibiting growth of organisms associated with chronic flaking and itching.

Do NOT use Dandrex Lotion if:

• you are allergic to any ingredient in Dandrex Lotion

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dandrex Lotion:

Some medical conditions may interact with Dandrex Lotion. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances

Some MEDICINES MAY INTERACT with Dandrex Lotion. Because little, if any, of Dandrex Lotion is absorbed into the blood, the risk of it interacting with another medicine is low.

Ask your health care provider if Dandrex Lotion may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dandrex Lotion:

Use Dandrex Lotion as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Shake well before each use.


• Remove jewelry before using Dandrex Lotion.


• Do not use on broken or inflamed skin or scalp.


• To use Dandrex Lotion on the scalp - Massage 1 or 2 teaspoonfuls of the medicine on the wet scalp. Leave on the scalp for 2 to 3 minutes. Rinse scalp thoroughly. Wash hands well after treatment. If you are using Dandrex Lotion before or after bleaching, tinting, or permanent waving of hair, rinse hair for at least 5 minutes in cool running water.


• To use Dandrex Lotion on the skin - Apply a sufficient amount to cover affected areas of the body. Lather well with a small amount of water. Leave the medicine on the skin for 10 minutes. Rinse thoroughly in the shower. Wash hands well after treatment.


• If you miss a dose of Dandrex Lotion, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once

Ask your health care provider any questions you may have about how to use Dandrex Lotion.

Important safety information:

• If your symptoms do not get better within 1 to 2 weeks or if they get worse, check with your doctor.


• Do NOT use for longer than prescribed without checking with your doctor.


• Do not get Dandrex Lotion in your eyes, or on the inside of your nose or mouth.


• Do not use Dandrex Lotion on broken or blistered skin.


• Do not apply Dandrex Lotion to the genital area. If you get Dandrex Lotion on your genitals, rinse thoroughly with water.


• Dandrex Lotion may damage jewelry. Remove jewelry before using Dandrex Lotion.


• Dandrex Lotion should not be used in CHILDREN younger than 2 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dandrex Lotion while you are pregnant. It is not known if Dandrex Lotion is found in breast milk. Do not breast-feed while taking Dandrex Lotion.

Possible side effects of Dandrex Lotion:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Hair discoloration (minimized by thorough rinsing); increase in mild hair loss or thinning; oiliness or dryness of hair and scalp.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dandrex side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center ( http://www.aapcc.org), or emergency room immediately. Dandrex Lotion may be harmful if swallowed.

Proper storage of Dandrex Lotion:

Store Dandrex Lotion below 86 degrees F (30 degrees C) in a tightly closed container. Store away from heat and light. Keep Dandrex Lotion out of the reach of children and away from pets.

General information:

• If you have any questions about Dandrex Lotion, please talk with your doctor, pharmacist, or other health care provider.


• Dandrex Lotion is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dandrex Lotion. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dandrex resources

• Dandrex Side Effects (in more detail)
• Dandrex Use in Pregnancy & Breastfeeding
• Dandrex Support Group
• 0 Reviews for Dandrex - Add your own review/rating

Compare Dandrex with other medications

• Seborrheic Dermatitis
• Tinea Versicolor

Sterolone

Sterolone may be available in the countries listed below.

Ingredient matches for Sterolone

Fluocinolone

Fluocinolone Acetonide is reported as an ingredient of Sterolone in the following countries:

• Italy

International Drug Name Search

Dealin

Dealin may be available in the countries listed below.

Ingredient matches for Dealin

Dequalinium Chloride

Dequalinium Chloride is reported as an ingredient of Dealin in the following countries:

• Taiwan

International Drug Name Search

Difin

Difin may be available in the countries listed below.

Ingredient matches for Difin

Diphenhydramine

Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Difin in the following countries:

• Bangladesh

International Drug Name Search

Lentaron

Lentaron may be available in the countries listed below.

Ingredient matches for Lentaron

Formestane

Formestane is reported as an ingredient of Lentaron in the following countries:

• Luxembourg

International Drug Name Search

Gentacil

Gentacil may be available in the countries listed below.

Ingredient matches for Gentacil

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentacil in the following countries:

• Ethiopia

International Drug Name Search

Ciklosporin IVAX

Ciklosporin IVAX may be available in the countries listed below.

Ingredient matches for Ciklosporin IVAX

Ciclosporin

Ciclosporin is reported as an ingredient of Ciklosporin IVAX in the following countries:

• Sweden

International Drug Name Search

Cathejell S

Cathejell S may be available in the countries listed below.

Ingredient matches for Cathejell S

Chlorhexidine

Chlorhexidine dihydrochloride (a derivative of Chlorhexidine) is reported as an ingredient of Cathejell S in the following countries:

• Germany

International Drug Name Search

Iodinated Glycerol

Iodinated Glycerol may be available in the countries listed below.

Ingredient matches for Iodinated Glycerol

Glycerol, Iodinated

Iodinated Glycerol (BAN) is also known as Glycerol, Iodinated (USAN)

International Drug Name Search

Glossary

BAN	British Approved Name
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tramadol Copyfarm

Tramadol Copyfarm may be available in the countries listed below.

Ingredient matches for Tramadol Copyfarm

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramadol Copyfarm in the following countries:

• Denmark

International Drug Name Search

Retrocar

Retrocar may be available in the countries listed below.

Ingredient matches for Retrocar

Zidovudine

Zidovudine is reported as an ingredient of Retrocar in the following countries:

• Peru

International Drug Name Search

Rigentex

Rigentex may be available in the countries listed below.

Ingredient matches for Rigentex

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Rigentex in the following countries:

• Italy

International Drug Name Search

Okacin

Okacin may be available in the countries listed below.

Ingredient matches for Okacin

Lomefloxacin

Lomefloxacin is reported as an ingredient of Okacin in the following countries:

• Israel


• Italy


• Peru


• Thailand


• Tunisia


• Turkey


• Vietnam

Lomefloxacin hydrochloride (a derivative of Lomefloxacin) is reported as an ingredient of Okacin in the following countries:

• Argentina


• Austria


• Bangladesh


• Belgium


• Brazil


• Colombia


• Czech Republic


• Estonia


• Germany


• Greece


• Hong Kong


• Hungary


• Latvia


• Luxembourg


• Malta


• Myanmar


• Oman


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Singapore


• Slovakia


• Sri Lanka


• Switzerland


• Venezuela

International Drug Name Search